HEALON5TM PRO Ophthalmic Viscoelastic Device
- Provides space creation and anterior chamber maintenance through its cohesive properties1,2
- Delivers outstanding protection of endothelial cells during the phacoemulsification process through its dispersive properties*1,3,5
- Helps maintain control during capsulorhexis, phacoemulsification, and IOL placement1,4
- Provides space creation and anterior chamber maintenance through its cohesive properties1,2
- Delivers outstanding protection of endothelial cells during the phacoemulsification process through its dispersive properties*1,3,5
- Helps maintain control during capsulorhexis, phacoemulsification, and IOL placement1,4
Specifications
Classification
| Viscoadaptive
|
|---|---|
Fill size
| 0.60 ml6
|
Molecular weight
| 3,200,000 Da6
|
Zero shear viscosity
| 1,300,000 – 12,600,000 mPas1
|
REFERENCES
1. DOF2016CT0020 – Evaluation of the rheological properties of HEALON™ PRO OVD and HEALON5™ PRO OVD. 2016-06-13.
2. Holmen, Jorgen B. Scheimpflug photography study of ophthalmic viscosurgical devices during simulated cataract surgery. J Cataract Refract Surg 2003;29(3):568-574. REF2014CT0081.
3. Holzer MP, et al. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg 2001; 27(2):213-218. REF2014OTH0024.
4. Tetz MR, et al. Clinical results of phacoemulsification with the use of HEALON5™ or VISCOAT. J Cataract Refract Surg 2001; 27(3):416-420. REF2014OTH0029.
5. DOF2018CT0001 - Clinical investigation of the bacterially derived HEALON5™ OVD. 2018-01-22.
6. HEALON5™ PRO OVD DfU – CE Central – Doc. #52-0543-00, current revision.
© Johnson & Johnson and its affiliates 2024.
For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.
